Solid Biosciences Inc. (SLDB) stock
SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.23−0.25 (-3.86%)
Close on Nov 17, 2026Market cap $668.01MP/E –Yield –
Solid Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Solid Biosciences's price to book ratio was 2.1× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 0.3× to 3.2×, with a median of 1.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.1× | +0.1 |
| 2025 | Dec 31, 2025 | 2.0× | +1.1 |
| 2024 | Dec 31, 2024 | 0.9× | +0.1 |
| 2023 | Dec 29, 2023 | 0.9× | +0.6 |
| 2022 | Dec 30, 2022 | 0.3× | −0.6 |
| 2021 | Dec 31, 2021 | 0.9× | −14.9 |
| 2020 | Dec 31, 2020 | 15.7× | +13.9 |
| 2019 | Dec 31, 2019 | 1.9× | −4.7 |
| 2018 | Dec 31, 2018 | 6.5× | – |
See a number that looks wrong?